Table of Contents

Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group.

• C E Lloyd,
• K A Matthews,
• R R Wing,
• and T J Orchard

Psychosocial factors and complications of IDDM. The Pittsburgh Epidemiology of Diabetes Complications Study. VIII.

• M Parillo,
• A Mura,
• C Iovine,
• A A Rivellese,
• M Lavicoli,
• and G Riccardi

Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulin.

• N Jameel,
• J A Pugh,
• B D Mitchell,
• and M P Stern

Dietary protein intake is not correlated with clinical proteinuria in NIDDM.

• H W Kohl,
• N F Gordon,
• J A Villegas,
• and S N Blair

Cardiorespiratory fitness, glycemic status, and mortality risk in men.

• S L Suter,
• J J Nolan,
• P Wallace,
• B Gumbiner,
• and J M Olefsky

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects.

• M C Turnin,
• R H Beddok,
• J P Clottes,
• P F Martini,
• R G Abadie,
• J C Buisson,
• C Soulé-Dupuy,
• M Bonneu,
• R Camaré,
• and J P Anton

Telematic expert system Diabeto. New tool for diet self-monitoring for diabetic patients.

• B Widom,
• M P Diamond,
• and D C Simonson

Alterations in glucose metabolism during menstrual cycle in women with IDDM.

• T Hauser,
• E W Kraegen,
• L V Campbell,
• P J Compton,
• C Sammut,
• and D J Chisholm

Assessment of experts' approach to insulin therapy and development of a simulator for diabetes insulin adjustment.

• P Z Zimmet

Kelly West Lecture 1991. Challenges in diabetes epidemiology--from West to the rest.

• M D Marcus,
• R R Wing,
• J Guare,
• E H Blair,
• and A Jawad

Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients.

• W Marhoffer,
• M Stein,
• E Maeser,
• and K Federlin

Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes.

• T Lingenfelser,
• W Renn,
• C Plonz,
• M Radjaipour,
• M Eggstein,
• and B Jakober

Catecholamine response during human and pork insulin-induced hypoglycemia in IDDM patients.

• N H Mezitis,
• S Heshka,
• V Saitas,
• T S Bailey,
• R Costa,
• and F X Pi-Sunyer

Combination therapy for NIDDM with biosynthetic human insulin and glyburide.

• D M Nathan,
• E Schreiber,
• H Fogel,
• S Mojsov,
• and J F Habener

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects.

• V R Panz,
• B I Joffe,
• J R Wing,
• F J Raal,
• and H C Seftel

Insulin-receptor activity in nondiabetic and diabetic urbanized South African black women.

• B E Klein,
• S E Moss,
• R Klein,
• and T S Surawicz

Serum cholesterol in Wisconsin epidemiologic study of diabetic retinopathy.

• K E Airaksinen and
• M J Koistinen

Association between silent coronary artery disease, diabetes, and autonomic neuropathy. Fact of fallacy?

• R R Wing

Don't throw out the baby with the bathwater. A commentary on very-low-calorie diets.

• K L Luskey

Possible links between amylin and diabetes. Amylin is released into the blood stream along with insulin.

• J Wakelee-Lynch

Interferon may offer first drug therapy for diabetic retinopathy. New research showing that alpha-interferon blocks new blood vessel formation in the iris of monkeys may point the way to new treatment for diabetes retinopathy.

• B H Brouhard

Advanced glycosylation end products (AGE) and diabetic nephropathy.

• B H Brouhard

An artificial pancreas: 14 yr of progress.

• B H Brouhard

Quality of life after kidney/pancreas transplantation.

• B N Campaigne

Influence of regional adiposity on atherogenic risk factors in men and women with type II diabetes.

• A D Baron and
• G Brechtel

Occurrence of Bezold-Jarisch reflex during hyperinsulinemic glucose clamp.

• M T November,
• M A Morris,
• J C Litton,
• and B Stabler

Stress buffering effect of psychological support in a diabetic camp.